Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy

Inclusion criteria

A patient is eligible for inclusion in this study if all of the following criteria apply:

• Age: 18-75 years of age
• Surgery: craniotomy under general anesthesia.
• American Society of Anesthesiologists (ASA) Status: ASA: I, II, or III
• Language: Fluent in the English language
• Informed Consent: Written informed consent must be obtained.

Exclusion criteria

A patient will not be eligible for inclusion in this study if any one or more of the following criteria apply within thirty days of patient enrollment in this clinical trial:

• Medical: Any condition that may impair a patient's ability to complete any of the study assessments or confound interpretation of results.
• Hypersensitivity: Patient has a known immediate or delayed hypersensitivity reaction or known idiosyncrasy to any of the two study medications, ondansetron, or aprepitant.
• Other Drugs: Patients should not be taking medications with known antiemetic properties (phenothiazines, butyrophenones, antihistamines), nor should they receive metoclopramide, or other antiemetics preoperatively or 12 hours before the scheduled surgical procedure.
• Pregnant or lactating females: A pregnancy test will be performed within 24 hours of entering the study for females of childbearing potential.
• Substance Abuse: Clinically significant abuse of substances (alcohol, illicit or prescribed medications) such that the patient is unable to provide informed consent or reliably complete any of the study assessments.
• Psychiatric Disease: History of a psychiatric illness that may impair the patient's ability to provide informed consent or complete any of the study assessments.
• Nausea verbal rating score (VRS): A VRS nausea score > 3 (scale 0-10) in the preoperative holding area before pretreatment with the study medications.